Wei Cui

机构：Shenyang Pharmaceutical University · ORCID：0000-0002-2049-0508

发表论文 81 篇 · 总被引 2741 次 · h-index 29

代表论文

• An EHMT2/NFYA-ALDH2 signaling axis modulates the RAF pathway to regulate paclitaxel resistance in lung cancer (2022 · Molecular Cancer · 被引 64)
• SIRPγ-expressing cancer stem-like cells promote immune escape of lung cancer via Hippo signaling (2022 · DOAJ (DOAJ: Directory of Open Access Journals) · 被引 55)
• Epigenetic enzyme mutations as mediators of anti-cancer drug resistance (2022 · Drug Resistance Updates · 被引 45)
• HNRNPA2B1 Affects the Prognosis of Esophageal Cancer by Regulating the miR-17-92 Cluster (2021 · Frontiers in Cell and Developmental Biology · 被引 43)
• Dl-3-n-butylphthalide promotes angiogenesis in ischemic stroke mice through upregulating autocrine and paracrine sonic hedgehog (2023 · Acta Pharmacologica Sinica · 被引 37)
• Gain-of-function mutations in the catalytic domain of DOT1L promote lung cancer malignant phenotypes via the MAPK/ERK signaling pathway (2023 · Science Advances · 被引 23)